1. Home
  2. BSX vs SNY Comparison

BSX vs SNY Comparison

Compare BSX & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Boston Scientific Corporation

BSX

Boston Scientific Corporation

HOLD

Current Price

$59.61

Market Cap

93.4B

Sector

Health Care

ML Signal

HOLD

Logo Sanofi ADS

SNY

Sanofi ADS

HOLD

Current Price

$47.27

Market Cap

107.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BSX
SNY
Founded
1979
1994
Country
United States
France
Employees
N/A
74846
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
93.4B
107.3B
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
BSX
SNY
Price
$59.61
$47.27
Analyst Decision
Strong Buy
Buy
Analyst Count
21
5
Target Price
$102.10
$58.00
AVG Volume (30 Days)
14.6M
2.5M
Earning Date
04-22-2026
04-23-2026
Dividend Yield
N/A
3.33%
EPS Growth
55.20
N/A
EPS
1.94
N/A
Revenue
$9,076,000,000.00
N/A
Revenue This Year
$11.85
$3.49
Revenue Next Year
$10.16
$6.10
P/E Ratio
$31.37
$6.14
Revenue Growth
12.49
N/A
52 Week Low
$60.59
$43.32
52 Week High
$109.50
$55.73

Technical Indicators

Market Signals
Indicator
BSX
SNY
Relative Strength Index (RSI) 31.54 52.68
Support Level N/A $47.07
Resistance Level $76.77 $48.49
Average True Range (ATR) 1.66 0.66
MACD 0.23 0.04
Stochastic Oscillator 4.55 47.43

Price Performance

Historical Comparison
BSX
SNY

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Share on Social Networks: